CEO Dr. Stuart Titus Addresses FDA About CBD Regulation - May 31, 2019

Medical Marijuana, Inc. CEO Dr. Stuart Titus addresses the U.S. Food and Drug Administration (FDA) on Friday, May 31, 2019, during the agency’s special public hearing to gather opinions on the regulation of cannabidiol (CBD). The first-of-its-kind FDA Public Hearing was meant to collect information about cannabis and its non-intoxicating compound CBD. Dr. Titus was invited to share his expertise on how to best approach regulating the cannabis compound CBD because of his extensive knowledge of CBD and can